Navigation Links
DNA Jewel to Finance Anti-Aging Services & Cancer Research
Date:12/15/2008

GENEVA, Switzerland, December 15 /PRNewswire/ -- Swiss-based http://www.dnartistic.com's first piece of DNA luxury jewellery will be sold at 1 million CHF and some of the proceeds will be used to finance the anti-aging services and life extension research of sister company http://www.inneova.com.

Dr. Ivan de Weber, a young Swiss scientist specialized in molecular genetics of aging and co-founder of both Inneova(TM) and DNArtistic has brought together a group of jewellers who work with the world's most exclusive brands including Chopard and Bulgari. They will integrate the DNA and genetic fingerprint of the jewel's future owner into the object via a fusion of molecular biology and jewellery-making.

DNArtistic already uses the concept of DNA identification to offer its clients DNA-inspired paintings. Similar technology allows clients to explore their ancestral origins at http://www.dnapast.com.

Inneova(TM), one of the first companies worldwide, provides adult cell cryobanking services to preserve human cells from the aging process. As cells deteriorate with age, Inneova(TM) allows its adult clients to freeze either their skin or bone cells (for newborns, umbilical cord cells), banking their "youth potential" for use in future anti-aging, rejuvenation and regeneration treatments.

Inneova(TM) also offers the most comprehensive range of predictive genetic tests available worldwide. These screen for risk factors and sensitivity to particular molecules to help physicians recommend further check-ups and optimize the choice of medications, diets, and cosmetics. In association with Knome(TM) Inneova(TM) offers whole genome sequencing, considered the most advanced genetic tool in predictive medicine.

To assure a complete range of a
'/>"/>

SOURCE Inneova Corporation Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Friends of Mel Announce Recall of Jewelry Due to Lead
2. GordonsJewelers.com Introduces The Pink Collection in Honor of Breast Cancer Awareness Month
3. Jewel-Osco Launches Flu Shot Program
4. Kay Jewelers Joins St. Jude Childrens Research Hospital(R) to Kick Off Fourth Annual Thanks and Giving(R) Campaign
5. Unique Gift for Valentines Day: Canine Cancer Campaign Customized Dog Tag - for Your Dog or as a Beautiful Piece of Jewelry for a Special Human
6. St. Valentines Day Wishes: Perfume? Jewelry? Labiaplasty?
7. St. Jude, Sterling Jewelers Inc. Celebrate Opening of Kay Kafe
8. Warning for teens: Teeth and jewelry dont mix
9. Jewel-Osco: 1 Million Reusable Shopping Bags Sold
10. Jewel-Osco Launches Prescription Plus Discount Program
11. JEWEL-OSCO(R) Extends Prescription Plus Rewards Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...in younger women may up chances of disease, study ...s) -- Mammograms may actually boost the risk of br...uggests. , Dutch researchers analyzed six previ... of low-dose radiation exposure from mammography a...st cancer risk and two looking at the effect of ra...
(Date:12/1/2009)... Pilots will enable local organizations to te...r for consumers who lack access , ...en Fund, a nonprofit venture firm addressing pover...t has selected four organizations in Kenya to cond... transportation and storage. , , ,The pilot progra...
(Date:12/1/2009)..., IRVINE, Calif., Dec. 1 ...CO-Oximetry(TM) and Measure-Through Motion and Low...arance of its latest innovation -- Masimo Rainbow ...sive and continuous respiration rate (RRa(TM)) tha...ompliance. Masimo Rainbow SET Acoustic Monitoring...
(Date:12/1/2009)... Free hearing aids will be given by Estes Aud... Austin, TX (PRWEB) December...m ), a professional hearing healthcare provider de...ired and their families, announced today the begin...giveaway. Each year, Estes Audiology donates two ...
(Date:12/1/2009)... All Federal and Georgia State Retirees who a.... This new benefit is part of the Medicare Advanta...fee for service (PFFS) Options offered by CIGNA, B...r Permanente. Atlanta Hearing Associates has three... Oconee / Greensboro, GA and Lake Sinclair / Mille...
Breaking Medicine News(10 mins):Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4
...to offer good news for older adults .The first stu... depression // in the elderly. Researchers studied...participants suffered from major depression, while...study show seniors who received the home-based pro...
...ng pneumonia may mean just a short-term lease on a...lts of the study show // increasing age combined w...e, an altered mental state, and anemia were signif...olled diabetes and a hematocrit (ratio of the volu...
...tion after heart surgery may not be the be the wis...archers.// A recent study confirms that corona...heart medications, such as beta blockers and ACE i...edication. However, this assumption was questioned...
...e conditions such as chronic bronchitis and emphys... // and gradual loss of lung function that cannot ...use of death in the United States. A test known...pirometry test and a screening questionnaire to de...
...tendon near a joint becomes inflamed. Treatment is... a new approach relieves the pain of this common c... with tendonitis are finding relief with extracorp...ave treatments to relieve the pain of chronic tend...
...dy researchers say zinc supplements may increase t...ttention deficit hyperactivity // disorder ( ADHD ...n of melatonin, which helps regulate dopamine func... of reward and pleasure. Zinc is a mineral tha...
Other Medicine News:
(Date:11/30/2009)...C., Nov. 30 Microban International...l product protection, is pleased to announce their... Corp., the largest U.S. manufacturer and distribu...orp is launching two new lines of ceramic tile wit...;) patent pending silver based technology, in orde...
(Date:11/30/2009)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI... technique for the detection of ductal carcinoma i...er. BSGI is a molecular breast imaging technique t...and discover very early stage cancers. According t...f the Radiological Society of North America (RSNA)...
(Date:11/30/2009)..., Nov. 30 SCOLR Pharma, ...vember 25, 2009, the NYSE Amex LLC (the "Exchange"...mpany,s plan to comply with its previously disclos... the Exchange Company Guide. Specifically, the de...losses which were so substantial in relation to it...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4University of Louisville neuroscientists hope to get people walking again 58667 1Experts gather at McGill University to address food security challenges 10216 1EPA reviews Univ of Michigan dioxin study 10212 1EPA reviews Univ of Michigan dioxin study 10212 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
.../See™ is a 1-step, hand-held, point-of-care ...ug metabolites in human urine. The TOX/See device... drugs in 3 to 8 minutes and requires only a few d...ly packaged to maximize convenience and ease of us...
ESR-10 Manual Rack
...eck Cytometry Concentrate is for use as a sheath f...ach 70ml bottle of Cytometry Concentrate dilutes t...d to Cubitainers, Streck Cytometry Concentrate red...es money without compromising performance. Streck ...
CD-Chex CD34 Leukocyte Control
Medicine Products: